Oxidative Stress in Transthyretin-Mediated Amyloidosis: An Exploratory Study.
FORD
FORT
amyloidosis
oxidative stress
transthyretin
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
18 Aug 2024
18 Aug 2024
Historique:
received:
10
07
2024
revised:
13
08
2024
accepted:
16
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Transthyretin-mediated amyloidosis (ATTR) is a systemic disease with protein precipitation in many tissues, mainly the peripheral nerve and heart. Both genetic (ATTRv, "v" for variant) and wild-type (ATTRwt) forms are known. Beyond the steric encumbrance, precipitated transthyretin seems to have a toxic effect. In this study carried out in men, we recruited 15 ATTRv patients, 7 ATTRv asymptomatic carriers, 14 ATTRwt patients and 10 young and 13 old healthy controls to evaluate the oxidative stress using FORD (Free Oxygen Radicals Defense) and FORT (Free Oxygen Radicals Test) analyses. ATTRv patients showed reduced FORD compared to ATTRwt and ATTRv asymptomatic carriers. FORD independently predicted the disease stage, with the early stages characterized by the highest consumption. These findings suggest a role for oxidative stress in the early stages of ATTRv.
Identifiants
pubmed: 39199243
pii: antiox13080998
doi: 10.3390/antiox13080998
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : This research was funded by Sapienza University of Rome through a research grant (ref. RM12218163F49C9E 2022).
ID : RM12218163F49C9E 2022